ProKidney Corp. (PROK) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
PROK EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PROK Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | -540.8% | -18477.8% | -16977.8% |
| 2024 | 100.0% | -241678.9% | -80507.9% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export PROK earnings history in CSV or JSON format
Free sign-in required to download data
ProKidney Corp. (PROK) Earnings Overview
As of May 8, 2026, ProKidney Corp. (PROK) reported trailing twelve-month net income of -$69M, reflecting +17.7% year-over-year growth. The company earned $-0.51 per diluted share over the past four quarters, with a net profit margin of -16977.8%.
Looking at the long-term picture, PROK's historical earnings data spans multiple years. The company achieved its highest annual net income of -$27M in fiscal 2020.
ProKidney Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RCKT (-$223M net income), FATE (-$136M net income, -2051.1% margin), NTLA (-$413M net income, -609.9% margin), PROK has comparable earnings metrics. Compare PROK vs RCKT →
PROK Earnings vs Peers
Earnings metrics vs comparable public companies
PROK Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$152M | -147.8% | -$165M | $-0.51 | -16977.8% | -18477.8% |
| 2024 | -$61M | -72.5% | -$184M | $-0.62 | -80507.9% | -241678.9% |
| 2023 | -$35M | +67.2% | -$152M | $-0.57 | - | - |
| 2022 | -$108M | -95.9% | -$153M | $-1.76 | - | - |
| 2021 | -$55M | -106.2% | -$55M | $-1.73 | - | - |
| 2020 | -$27M | +66.4% | -$27M | $-0.14 | - | - |
| 2019 | -$80M | - | -$79M | $-1.01 | - | - |
See PROK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PROK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PROK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPROK — Frequently Asked Questions
Quick answers to the most common questions about buying PROK stock.
Is PROK growing earnings?
PROK EPS is $-0.51, with earnings growth accelerating to +17.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-69M.
What are PROK's profit margins?
ProKidney Corp. net margin is -16977.8%, with operating margin at -18477.8%. Below-average margins reflect competitive or cost pressures.
How consistent are PROK's earnings?
PROK earnings data spans 2019-2025. The accelerating earnings trend is +17.7% YoY. Historical data enables comparison across business cycles.